Prevention of Treatment Induced Neuropathy in Multiple Myeloma
Status:
Active, not recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to see if Minocin® (minocycline) can help to
control nerve damage that causes numbness and tingling in the hands and feet (neuropathy) in
patients receiving thalidomide and/or bortezomib.